Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

thyroid gland diffuse sclerosing papillary carcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

thyroid gland diffuse sclerosing papillary carcinoma

MONDO:0003701

Also known as:nonencapsulated sclerosing adenocarcinomanonencapsulated sclerosing carcinomanonencapsulated sclerosing neoplasm

Overview

A morphologic variant of papillary carcinoma of the thyroid gland that more often affects young patients and commonly metastasizing to the lungs. It is characterized by a diffuse infiltration of the thyroid gland by malignant follicular cells, squamous metaplasia, stromal fibrosis, and lymphocytic infiltration.

ResearchLimited published research (6 articles)

Diagnosis

Biomarker and diagnostic research for thyroid gland diffuse sclerosing papillary carcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for thyroid gland diffuse sclerosing papillary carcinoma.

6 publications have been identified in PubMed for thyroid gland diffuse sclerosing papillary carcinoma. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (17%), and Clinical Trial Publication (17%).

Recent Publications

Dixit S (2026). [PMID: 41545802](https://pubmed.ncbi.nlm.nih.gov/41545802/). *Virchows Arch*. [Basic Science / Preclinical]
Latia M (2026). [PMID: 41594321](https://pubmed.ncbi.nlm.nih.gov/41594321/). *Diagnostics (Basel)*. [Case Report / Case Series]
Kuerten P (2026). [PMID: 42116127](https://pubmed.ncbi.nlm.nih.gov/42116127/). *Cytopathology*. [Epidemiology / Natural History]
Frich PS (2025). [PMID: 40405530](https://pubmed.ncbi.nlm.nih.gov/40405530/). *J Clin Endocrinol Metab*. [Clinical Trial Publication]
Chen Z (2025). [PMID: 39552056](https://pubmed.ncbi.nlm.nih.gov/39552056/). *J Clin Endocrinol Metab*. [Diagnostic / Biomarker]

Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 10:42 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

thyroid gland diffuse sclerosing papillary carcinoma

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team